Fredun Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results
Fredun Pharmaceuticals Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Fredun Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results Fredun Pharmaceuticals Limited announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI Insider Trading regulations, the company's trading window for dealing in its securities has been closed since 1st Oct'26 and will remain closed until 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Fredun Pharmaceuticals Ltd
- Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited. 路 16 Nov 2026
- Outcome of the Board Meeting of 'Fredun Pharmaceuticals Limited' ('Company') pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 路 14 Nov 2026
- Report of Monitoring Agency on the use of proceeds raised through Preferential Allotment for the quarters ended March 31, 2026, June 30,2026 and September30, 2026. 路 14 Nov 2026
- Statement of Deviation or Variation For the Quarter Ended September 30, 2026 for the Funds raised through Preferential Issue. 路 14 Nov 2026
- Intimation of Earnings Conference Call for the Quarter Q2 of FY27 路 16 Nov 2026
- Press Release 路 06 Nov 2026
- Approval for National Stock Exchange of India Limited (NSE) Listing Application. 路 05 Nov 2026
- Financial results for the quarter ended 30th September, 2026. 路 05 Nov 2026
